Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration.

Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albigès, Chris Wang, Philippe Beuzeboc, Marine Gross-Goupil, Thibault de La Motte Rouge, Aline Guillot, Dorota Gajda, Christophe Massard, Martin Gleave, Karim Fizazi, Yohann Loriot, Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies European Urology. ,vol. 68, pp. 228- 235 ,(2015) , 10.1016/J.EURURO.2014.04.015

Ryota Kikuchi, Yanbin Lao, Daniel AJ Bow, William J Chiou, Mark E Andracki, Robert A Carr, Richard L Voorman, Sonia M De Morais, None, Prediction of Clinical Drug–Drug Interactions of Veliparib (ABT-888) with Human Renal Transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K) Journal of Pharmaceutical Sciences. ,vol. 102, pp. 4426- 4432 ,(2013) , 10.1002/JPS.23737

Elliot G. Brown, Louise Wood, Sue Wood, The medical dictionary for regulatory activities (MedDRA). Drug Safety. ,vol. 20, pp. 109- 117 ,(1999) , 10.2165/00002018-199920020-00002

C. Parker, S. Gillessen, A. Heidenreich, A. Horwich, Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology. ,vol. 26, ,(2015) , 10.1093/ANNONC/MDV222

Carmel J. Pezaro, Aurelius G. Omlin, Amelia Altavilla, David Lorente, Roberta Ferraldeschi, Diletta Bianchini, David Dearnaley, Christopher Parker, Johann S. de Bono, Gerhardt Attard, Activity of Cabazitaxel in Castration-resistant Prostate Cancer Progressing After Docetaxel and Next-generation Endocrine Agents European Urology. ,vol. 66, pp. 459- 465 ,(2014) , 10.1016/J.EURURO.2013.11.044

Yvette Drew, Evan A. Mulligan, Wan-Tse Vong, Huw D. Thomas, Samra Kahn, Suzanne Kyle, Asima Mukhopadhyay, Gerrit Los, Zdenek Hostomsky, Elizabeth R. Plummer, Richard J. Edmondson, Nicola J. Curtin, Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2 Journal of the National Cancer Institute. ,vol. 103, pp. 334- 346 ,(2011) , 10.1093/JNCI/DJQ509

Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Emma Sawyer, Rosemary Wilkinson, Audrey Ardern-Jones, Steve Ellis, Debra Frost, Susan Peock, D Gareth Evans, Marc Tischkowitz, Trevor Cole, Rosemarie Davidson, Diana Eccles, Carole Brewer, Fiona Douglas, Mary E Porteous, Alan Donaldson, Huw Dorkins, Louise Izatt, Jackie Cook, Shirley Hodgson, M John Kennedy, Lucy E Side, Jacqueline Eason, Alex Murray, Antonis C Antoniou, Douglas F Easton, Zsofia Kote-Jarai, Rosalind Eeles, None, Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer Journal of Clinical Oncology. ,vol. 31, pp. 1748- 1757 ,(2013) , 10.1200/JCO.2012.43.1882

Y. Loriot, D. Bianchini, E. Ileana, S. Sandhu, A. Patrikidou, C. Pezaro, L. Albiges, G. Attard, K. Fizazi, J.S. De Bono, C. Massard, Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100) Annals of Oncology. ,vol. 24, pp. 1807- 1812 ,(2013) , 10.1093/ANNONC/MDT136

Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew, Lovise Mæhle, Karol Axcrona, D Gareth Evans, Barbara Bulman, Diana Eccles, Donna McBride, Christi Van Asperen, Hans Vasen, Lambertus A Kiemeney, Janneke Ringelberg, Cezary Cybulski, Dominika Wokolorczyk, Christina Selkirk, Peter J Hulick, Anders Bojesen, Anne-Bine Skytte, Jimmy Lam, Louise Taylor, Rogier Oldenburg, Ruben Cremers, Gerald Verhaegh, Wendy A van Zelst-Stams, Jan C Oosterwijk, Ignacio Blanco, Monica Salinas, Jackie Cook, Derek J Rosario, Saundra Buys, Tom Conner, Margreet G Ausems, Kai-ren Ong, Jonathan Hoffman, Susan Domchek, Jacquelyn Powers, Manuel R Teixeira, Sofia Maia, William D Foulkes, Nassim Taherian, Marielle Ruijs, Apollonia T Helderman-van den Enden, Louise Izatt, Rosemarie Davidson, Muriel A Adank, Lisa Walker, Rita Schmutzler, Kathy Tucker, Judy Kirk, Shirley Hodgson, Marion Harris, Fiona Douglas, Geoffrey J Lindeman, Janez Zgajnar, Marc Tischkowitz, Virginia E Clowes, Rachel Susman, Teresa Ramón y Cajal, Nicholas Patcher, Neus Gadea, Allan Spigelman, Theo Van Os, Annelie Liljegren, Lucy Side, Carole Brewer, Angela F Brady, Alan Donaldson, Vigdis Stefansdottir, Eitan Friedman, Rakefet Chen-Shtoyerman, David J Amor, Lucia Copakova, Julian Barwell, Veda N Giri, Vedang Murthy, Nicola Nicolai, Soo-Hwang Teo, Lynn Greenhalgh, Sara Strom, Alex Henderson, John McGrath, David Gallagher, Neil Aaronson, Audrey Ardern-Jones, Chris Bangma, David Dearnaley, Philandra Costello, Jorunn Eyfjord, Jeanette Rothwell, Alison Falconer, Henrik Gronberg, Freddie C Hamdy, Oskar Johannsson, Vincent Khoo, Zsofia Kote-Jarai, Jan Lubinski, Ulrika Axcrona, Jane Melia, Joanne McKinley, Anita V Mitra, Clare Moynihan, Gad Rennert, Mohnish Suri, Penny Wilson, Emma Killick, Sue Moss, Rosalind A Eeles, Impact Collaborators, None, Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study European Urology. ,vol. 66, pp. 489- 499 ,(2014) , 10.1016/J.EURURO.2014.01.003

P.A. Tang, G.R. Pond, E.X. Chen, Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials Annals of Oncology. ,vol. 21, pp. 19- 26 ,(2010) , 10.1093/ANNONC/MDP478